180
Views
30
CrossRef citations to date
0
Altmetric
Original Article

The associations of circulating CD4+CD25high regulatory T cells and TGF-β with disease activity and clinical course in patients with adult-onset Still's disease

, , , , &
Pages 370-377 | Received 11 Sep 2009, Accepted 03 Nov 2009, Published online: 13 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ju-Yang Jung, Chang-Hee Suh & Hyoun-Ah Kim. (2019) The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still’s disease. Expert Review of Molecular Diagnostics 19:6, pages 459-468.
Read now
Piero Ruscitti & Roberto Giacomelli. (2018) Pathogenesis of adult onset still’s disease: current understanding and new insights. Expert Review of Clinical Immunology 14:11, pages 965-976.
Read now

Articles from other publishers (28)

Xinglan He, Ruixuan You, Yaqian Shi, Zhuotong Zeng, Bingsi Tang, Jiangfan Yu, Yangfan Xiao & Rong Xiao. (2023) Pyroptosis: the potential eye of the storm in adult-onset Still’s disease. Inflammopharmacology.
Crossref
Stefan Vordenbäumen, Eugen Feist, Jürgen Rech, Martin Fleck, Norbert Blank, Johannes-Peter Haas, Ina Kötter, Martin Krusche, Gamal Chehab, Bimba Hoyer, Uta Kiltz, Dorothea Fell, Julia Reiners, Christiane Weseloh, Matthias Schneider & Jürgen Braun. (2022) Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guidelineDiagnostik und Behandlung bei M. Still des Erwachsenen: kurze Zusammenfassung der S2-Leitlinie der Deutschen Gesellschaft für Rheumatologie. Zeitschrift für Rheumatologie 82:S2, pages 81-92.
Crossref
Stefan Vordenbäumen, Eugen Feist, Jürgen Rech, Martin Fleck, Norbert Blank, Johannes-Peter Haas, Ina Kötter, Martin Krusche, Gamal Chehab, Bimba Hoyer, Uta Kiltz, Dorothea Fell, Julia Reiners, Christiane Weseloh, Matthias Schneider & Jürgen Braun. (2022) DGRh-S2e-LeitlinieDGRh S2e guidelines. Zeitschrift für Rheumatologie 81:S1, pages 1-20.
Crossref
Jasper F. Nies, Udo Schneider & Martin Krusche. (2022) Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review. Frontiers in Medicine 9.
Crossref
Shijia Rao, Lemuel Shui-Lun Tsang, Ming Zhao, Wei Shi & Qianjin Lu. (2022) Adult-onset Still’s disease: A disease at the crossroad of innate immunity and autoimmunity. Frontiers in Medicine 9.
Crossref
Bowen Xu, Jian Wang, Xiaoying Meng & Binghao Bao. (2022) Bibliometrics and Visual Analysis of Adult-onset Still Disease (1976–2020). Frontiers in Public Health 10.
Crossref
Tatiana Mayumi Veiga Iriyoda, Tamires Flauzino, Neide Tomimura Costa, Marcell Alysson Batisti Lozovoy, Edna Maria Vissoci Reiche & Andréa Name Colado Simão. (2021) TGFB1 (rs1800470 and rs1800469) variants are independently associated with disease activity and autoantibodies in rheumatoid arthritis patients. Clinical and Experimental Medicine 22:1, pages 37-45.
Crossref
E. L. Nasonov & E. Feist. (2021) Adult Still's disease: New horizons. Rheumatology Science and Practice 59:6, pages 645-665.
Crossref
Piero Ruscitti, Onorina Berardicurti, Roberto Giacomelli & Paola Cipriani. (2021) The clinical heterogeneity of adult onset Still’s disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients. Seminars in Immunology 58, pages 101632.
Crossref
Yasuhiro Shimojima, Takanori Ichikawa, Dai Kishida, Ryota Takamatsu & Yoshiki Sekijima. (2021) Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability. Clinical and Experimental Immunology 206:2, pages 184-195.
Crossref
Khetam Ghannam, Jan Zernicke, Claudia Kedor, Joachim Listing, Gerd-R. Burmester, Dirk Foell & Eugen Feist. (2021) Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab. Journal of Clinical Medicine 10:19, pages 4400.
Crossref
Yuning Ma, Jianfen Meng, Jinchao Jia, Mengyan Wang, Jialin Teng, Dehao Zhu, Chengde Yang & Qiongyi Hu. (2021) Current and emerging biological therapy in adult-onset Still’s disease. Rheumatology 60:9, pages 3986-4000.
Crossref
Yong Du, Chun Xie, Sneha Ravikumar, Jacob Orme, Li Li, Xin J Zhou & Chandra Mohan. (2021) Heightened Crescentic Glomerulonephritis in Immune Challenged 129sv Mice Is TGF-β/Smad3 Dependent. International Journal of Molecular Sciences 22:4, pages 2059.
Crossref
Sheng Li, Siting Zheng, Shunli Tang, Yunlei Pan, Shan Zhang, Hong Fang & Jianjun Qiao. (2019) Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease. Clinical Reviews in Allergy & Immunology 58:1, pages 71-81.
Crossref
Meng-Yan Wang, Jin-Chao Jia, Cheng-De Yang & Qiong-Yi Hu. (2019) Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review. Chinese Medical Journal 132:23, pages 2856-2864.
Crossref
Joanna Giemza-Stokłosa, Md. Asiful Islam & Przemysław J. Kotyla. (2019) Hyperferritinaemia: An Iron Sword of Autoimmunity. Current Pharmaceutical Design 25:27, pages 2909-2918.
Crossref
Roberto Giacomelli, Piero Ruscitti & Yehuda Shoenfeld. (2018) A comprehensive review on adult onset Still's disease. Journal of Autoimmunity 93, pages 24-36.
Crossref
Paolo Sfriso, Sara Bindoli & Paola Galozzi. (2018) Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances. Drugs 78:12, pages 1187-1195.
Crossref
Santos Castañeda, Esther F. Vicente & Miguel A. González-Gay. (2016) Enfermedad de Still del adulto. Medicina Clínica 147:5, pages 217-222.
Crossref
Santos Castañeda, Esther F. Vicente & Miguel A. González-Gay. (2016) Adult-onset Still's disease. Medicina Clínica (English Edition) 147:5, pages 217-222.
Crossref
Santos Castañeda, Ricardo Blanco & Miguel A. González-Gay. (2016) Adult-onset Still's disease: Advances in the treatment. Best Practice & Research Clinical Rheumatology 30:2, pages 222-238.
Crossref
M. Gerfaud-Valentin, P. Sève, A. Hot, C. Broussolle & Y. Jamilloux. (2015) Données actualisées sur la physiopathologie, les phénotypes et les traitements de la maladie de Still de l’adulte. La Revue de Médecine Interne 36:5, pages 319-327.
Crossref
Yvan Jamilloux, Mathieu Gerfaud-Valentin, Fabio Martinon, Alexandre Belot, Thomas Henry & Pascal Sève. (2014) Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart. Immunologic Research 61:1-2, pages 53-62.
Crossref
Mathieu Gerfaud-Valentin, Yvan Jamilloux, Jean Iwaz & Pascal Sève. (2014) Adult-onset Still's disease. Autoimmunity Reviews 13:7, pages 708-722.
Crossref
Chunhua Xun, Yong Zhao & Zhi jian Hu. (2012) Potential role of adenosine deaminase in the diagnosis of adult-onset Still’s disease. Rheumatology International 33:5, pages 1255-1258.
Crossref
Weng Seng Fong & Nai Lee Lui. (2013) Adult-Onset Still's Disease: A Review. Proceedings of Singapore Healthcare 22:1, pages 40-47.
Crossref
Clio P. Mavragani, Evangelos G. Spyridakis & Michael Koutsilieris. (2012) Adult-Onset Still’s Disease: From Pathophysiology to Targeted Therapies. International Journal of Inflammation 2012, pages 1-10.
Crossref
SONG GUO ZHENG. (2010) Transforming Growth Factor-β Level: Indicator for Severity of Disease and Organ Damage in Patients with Systemic Lupus Erythematosus: Figure 1.. The Journal of Rheumatology 37:10, pages 1983-1985.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.